Format

Send to

Choose Destination
See comment in PubMed Commons below
J Occup Environ Med. 2011 Feb;53(2):204-10. doi: 10.1097/JOM.0b013e318209e0ce.

The relationship between patient-reported tolerability issues with oral antidiabetic agents and work productivity among patients having type 2 diabetes.

Author information

1
Kantar Health, New York, NY, USA. marco.dibonaventura@kantarhealth.com

Abstract

OBJECTIVE:

To investigate the association between reported oral antidiabetic tolerability issues and work productivity, activity impairment, and indirect costs.

METHODS:

Data were collected from the 2006 to 2008 US National Health and Wellness Survey and the Lightspeed Research, using an Internet-based questionnaire (N = 2074).

RESULTS:

Absenteeism, presenteeism, overall work impairment, and activity impairment increased as the number of tolerability issues increased. Similar results were observed using a diabetes-specific productively measure. Total annual adjusted indirect costs (absenteeism and presenteeism costs summed) were $2759, $5533, $7537, and $8405 for patients with 1, 2, 3, and 4 or more tolerability issues, respectively.

CONCLUSIONS:

The consideration of tolerability profiles of oral antidiabetic agents may lead to improved productivity among treated patients. Furthermore, targeted educational programs regarding risks and management of these issues to employees with type 2 diabetes mellitus may benefit both employers and patients.

PMID:
21270651
DOI:
10.1097/JOM.0b013e318209e0ce
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center